The Acessa procedure allows for a thorough and minimally invasive method of treating your fibroids. It was designed to preserve healthy uterine tissue by focusing treatment only on the fibroid (versus cutting into the uterus or removing it completely) while relieving symptoms caused by fibroids.
Unlike many alternative interventions, the Acessa procedure optimizes imaging of the uterus by simultaneously displaying the laparoscopic camera view and the ultrasound view in real-time, so physicians can identify and treat nearly all locations of fibroids, including those outside the uterine cavity and within uterine walls. Women typically experience minimal discomfort after the procedure, quick return to work in 4-5 days, and long term satisfaction and relief.
This procedure is for pre-menopausal women (typically younger than 55 years old) who are tired of living with the ongoing pain and discomfort of fibroid symptoms and are looking for a minimally invasive option that allows them to keep their uterus and return to daily life quickly after the procedure.
Studies show that fibroids do not have to be completely removed to resolve symptoms. Treating the fibroid cells so they shrink and stop putting pressure on the uterus may help to resolve symptoms. The data in the IDE clinical study showed even a 45.1% average shrinkage in fibroid volume can result in significant improvement in heavy periods, pelvic pain and bulk. As a reminder, Acessa is a treatment for benign (non-cancerous) symptomatic fibroids. If patients are at risk for cancer or malignancy, Acessa is not the appropriate treatment.
Size and Number of Fibroids Treated
Size and number of fibroids are important factors in what procedure is right for you. That is why physicians order an MRI or ultrasound prior to determining if you are a candidate for the procedure. A physician can treat any number of fibroids present1. The number of fibroids that a physician is able to treat in a single procedure may vary. The ability to treat more fibroids thanks to laparoscopic ultrasound imaging can be an advantage of Acessa compared to myomectomy. The safety and effectiveness of the Acessa procedure has not been evaluated in women with uterine size greater than 14 weeks (which roughly equates to a single ~9 cm diameter fibroid)